Copyright 2018 Emmaus Medical, Inc. All rights reserved.
Endari™ is registered trademark of Emmaus Medical, Inc.
Endari™ [L-glutamine oral powder] is an FDA-approved prescription drug indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.
IMPORTANT SAFETY INFORMATION
Endari’s safety profile was similar to placebo and well-tolerated in pediatric and adult patients. The most common adverse reactions occurring in greater than 10 percent of patients treated with Endari were constipation, nausea, headache, abdominal pain, cough, pain in extremity, back pain, and chest pain (non-cardiac).
Endari should only be taken under the direction of a physician. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.
For additional information about Endari, please read the Endari Full Prescribing Information and talk to your doctor. You can also call 1-877-420-6493. Endari is available by prescription only.
You may report side effects to FDA at 1-800-FDA-1088.